The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
Specifically, individuals with a genetic variation in the melatonin receptor gene, which enhances melatonin's effect on the pancreas, face a higher risk of developing type 2 diabetes than those without this variation.
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
a certain variation in the Melatonin receptor 1B was identified to be a pretty high risk factor for developing type 2 diabetes and for uh having basically insulin disregulation